1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transarterial Radioembolization (TARE) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Microspheres
1.2.3 Particles
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres
1.3 Market by Application
1.3.1 Global Transarterial Radioembolization (TARE) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Transarterial Radioembolization (TARE) Market Perspective (2017-2028)
2.2 Transarterial Radioembolization (TARE) Growth Trends by Region
2.2.1 Transarterial Radioembolization (TARE) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transarterial Radioembolization (TARE) Historic Market Size by Region (2017-2022)
2.2.3 Transarterial Radioembolization (TARE) Forecasted Market Size by Region (2023-2028)
2.3 Transarterial Radioembolization (TARE) Market Dynamics
2.3.1 Transarterial Radioembolization (TARE) Industry Trends
2.3.2 Transarterial Radioembolization (TARE) Market Drivers
2.3.3 Transarterial Radioembolization (TARE) Market Challenges
2.3.4 Transarterial Radioembolization (TARE) Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue
3.1.1 Global Top Transarterial Radioembolization (TARE) Players by Revenue (2017-2022)
3.1.2 Global Transarterial Radioembolization (TARE) Revenue Market Share by Players (2017-2022)
3.2 Global Transarterial Radioembolization (TARE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transarterial Radioembolization (TARE) Revenue
3.4 Global Transarterial Radioembolization (TARE) Market Concentration Ratio
3.4.1 Global Transarterial Radioembolization (TARE) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transarterial Radioembolization (TARE) Revenue in 2021
3.5 Transarterial Radioembolization (TARE) Key Players Head office and Area Served
3.6 Key Players Transarterial Radioembolization (TARE) Product Solution and Service
3.7 Date of Enter into Transarterial Radioembolization (TARE) Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Transarterial Radioembolization (TARE) Breakdown Data by Type
4.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Type (2017-2022)
4.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2023-2028) 5 Transarterial Radioembolization (TARE) Breakdown Data by Application
5.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Application (2017-2022)
5.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Transarterial Radioembolization (TARE) Market Size (2017-2028)
6.2 North America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
6.3 North America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Transarterial Radioembolization (TARE) Market Size (2017-2028)
7.2 Europe Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
7.3 Europe Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Transarterial Radioembolization (TARE) Market Size (2017-2028)
8.2 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
8.3 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Transarterial Radioembolization (TARE) Market Size (2017-2028)
9.2 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
9.3 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Transarterial Radioembolization (TARE) Market Size (2017-2028)
10.2 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2017-2022)
10.3 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Sirtex Medical
11.1.1 Sirtex Medical Company Detail
11.1.2 Sirtex Medical Business Overview
11.1.3 Sirtex Medical Transarterial Radioembolization (TARE) Introduction
11.1.4 Sirtex Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.1.5 Sirtex Medical Recent Development
11.2 Merit Medical
11.2.1 Merit Medical Company Detail
11.2.2 Merit Medical Business Overview
11.2.3 Merit Medical Transarterial Radioembolization (TARE) Introduction
11.2.4 Merit Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.2.5 Merit Medical Recent Development
11.3 Cook Medical
11.3.1 Cook Medical Company Detail
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Transarterial Radioembolization (TARE) Introduction
11.3.4 Cook Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.3.5 Cook Medical Recent Development
11.4 BTG Medical
11.4.1 BTG Medical Company Detail
11.4.2 BTG Medical Business Overview
11.4.3 BTG Medical Transarterial Radioembolization (TARE) Introduction
11.4.4 BTG Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.4.5 BTG Medical Recent Development
11.5 Boston Scientific Corporation
11.5.1 Boston Scientific Corporation Company Detail
11.5.2 Boston Scientific Corporation Business Overview
11.5.3 Boston Scientific Corporation Transarterial Radioembolization (TARE) Introduction
11.5.4 Boston Scientific Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.5.5 Boston Scientific Corporation Recent Development
11.6 Terumo Corporation
11.6.1 Terumo Corporation Company Detail
11.6.2 Terumo Corporation Business Overview
11.6.3 Terumo Corporation Transarterial Radioembolization (TARE) Introduction
11.6.4 Terumo Corporation Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.6.5 Terumo Corporation Recent Development
11.7 HENGRUI Medical
11.7.1 HENGRUI Medical Company Detail
11.7.2 HENGRUI Medical Business Overview
11.7.3 HENGRUI Medical Transarterial Radioembolization (TARE) Introduction
11.7.4 HENGRUI Medical Revenue in Transarterial Radioembolization (TARE) Business (2017-2022)
11.7.5 HENGRUI Medical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
